Literature DB >> 18338978

[SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients].

José-Vicente Torregrosa1, Jorge Cannata Andia, Jordi Bover, Francisco Caravaca, Víctor Lorenzo, Angel Luis Martín de Francisco, Alejandro Martín-Malo, Isabel Martínez, Emilio González Parra, Elvira Fernández Giráldez, Mariano Rodríguez Portillo.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18338978

Source DB:  PubMed          Journal:  Nefrologia        ISSN： 0211-6995            Impact factor:   2.033


× No keyword cloud information.
  7 in total

1.  What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?

Authors:  Pablo Molina; José L Górriz; Mariola D Molina; Sandra Beltrán; Belén Vizcaíno; Verónica Escudero; Julia Kanter; Ana I Ávila; Jordi Bover; Elvira Fernández; Javier Nieto; Secundino Cigarrán; Enrique Gruss; Gema Fernández-Juárez; Alberto Martínez-Castelao; Juan F Navarro-González; Ramón Romero; Luis M Pallardó
Journal:  World J Nephrol       Date:  2016-09-06

Review 2.  A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument.

Authors:  Nigar Sekercioglu; Reem Al-Khalifah; Joycelyne Efua Ewusie; Rosilene M Elias; Lehana Thabane; Jason W Busse; Noori Akhtar-Danesh; Alfonso Iorio; Tetsuya Isayama; Juan Pablo Díaz Martínez; Ivan D Florez; Gordon H Guyatt
Journal:  Int Urol Nephrol       Date:  2016-11-01       Impact factor: 2.370

3.  Vascular calcification in patients with nondialysis CKD over 3 years.

Authors:  José L Górriz; Pablo Molina; M Jesús Cerverón; Rocío Vila; Jordi Bover; Javier Nieto; Guillermina Barril; Alberto Martínez-Castelao; Elvira Fernández; Verónica Escudero; Celestino Piñera; Teresa Adragao; Juan F Navarro-Gonzalez; Luis M Molinero; Cristina Castro-Alonso; Luis M Pallardó; Sophie A Jamal
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-13       Impact factor: 8.237

4.  Undetectable serum calcidiol: not everything that glitters is gold.

Authors:  Gioconda Gallegos-Bayas; José Francisco Pascual-Pareja; Maria D Sanchez-Niño; Felix Manzarbeitia; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2012-01-28

5.  Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5.

Authors:  César Augusto Restrepo Valencia; José Vicente Aguirre Arango
Journal:  Colomb Med (Cali)       Date:  2016-09-30

6.  A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients.

Authors:  Ricardo Villa-Bellosta; Laura Rodriguez-Osorio; Sebastian Mas; Younes Abadi; Mercedes Rubert; Concepción de la Piedra; Carolina Gracia-Iguacel; Ignacio Mahillo; Alberto Ortiz; Jesús Egido; Emilio González-Parra
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

7.  Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism.

Authors:  Ariadna Pérez-Ricart; Maria Galicia-Basart; Dolors Comas-Sugrañes; Josep-Maria Cruzado-Garrit; Alfons Segarra-Medrano; José-Bruno Montoro-Ronsano
Journal:  Kidney Res Clin Pract       Date:  2019-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.